Brandywine Oak Private Wealth’s iBio IBIO Stock Holding History

Brandywine Oak Private Wealth’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	–	–	395
2018 Q4	$0	Buy	+1	New	+$387	﹤0.01%	717

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brandywine Oak Private Wealth's IBIO Position: Q1 2019 in Review

Brandywine Oak Private Wealth sold out of iBio (IBIO) in Q1 2019, closing a stake of 1 share.

Brandywine Oak Private Wealth first reported a position in IBIO in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 13 funds tracked by Wall St. Rank hold IBIO as of Q1 2019.

Brandywine Oak Private Wealth reported no remaining iBio position as of Q1 2019 after selling out during the quarter.
Brandywine Oak Private Wealth sold 1 iBio share in Q1 2019.
Brandywine Oak Private Wealth first reported a position in iBio in Q4 2018 and held it in 1 quarter.
Brandywine Oak Private Wealth's iBio position peaked at $0 in Q4 2018.
13 funds tracked by Wall St. Rank held iBio as of Q1 2019.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2019, filed 9 May 2019.